Cargando…

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Both steatosis and inflammation are key pathological events in the progression of non-alcoholic fatty liver disease (NAFLD). Probiotics are beneficial for the prevention and treatment of NAFLD. Bifidobacterium animalis subsp. lactis V9 (V9) is a newly isolated strain with favorable probiotic propert...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Yan, Liu, Chunyan, Zhao, Shimin, Wang, Xinxu, Wang, Jinling, Zhang, Heping, Wang, Yuzhen, Zhao, Guofen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260323/ https://www.ncbi.nlm.nih.gov/pubmed/32472368 http://dx.doi.org/10.1186/s13568-020-01038-y

Ejemplares similares

In Vitro Probiotic Properties of Bifidobacterium animalis subsp. lactis SF and Its Alleviating Effect on Non-Alcoholic Fatty Liver Disease
por: Lv, Huihui, et al.
Publicado: (2023)

Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis
por: Zhang, Jiachao, et al.
Publicado: (2019)

The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®)
por: Jungersen, Mikkel, et al.
Publicado: (2014)

Use of the Probiotic Bifidobacterium animalis subsp. lactis HN019 in Oral Diseases
por: Araujo, Lisa Danielly Curcino, et al.
Publicado: (2022)

Updated Genome Sequence for the Probiotic Bacterium Bifidobacterium animalis subsp. lactis BB-12
por: Jensen, Kristian, et al.
Publicado: (2021)

Bifidobacterium lactis TY-S01 protects against alcoholic liver injury in mice by regulating intestinal barrier function and gut microbiota
por: Shu, Xi, et al.
Publicado: (2023)

Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis
por: Wang, Linlin, et al.
Publicado: (2021)

In vitro Study of Bifidobacterium lactis BL-99 With Fructooligosaccharide Synbiotics Effected on the Intestinal Microbiota
por: Zhang, Qi, et al.
Publicado: (2022)

Bifidobacterium animalis subsp. lactis A6 Enhances Fatty Acid β-Oxidation of Adipose Tissue to Ameliorate the Development of Obesity in Mice
por: Huo, Yanxiong, et al.
Publicado: (2022)

Promotility Action of the Probiotic Bifidobacterium lactis HN019 Extract Compared with Prucalopride in Isolated Rat Large Intestine
por: Dalziel, Julie E., et al.
Publicado: (2017)

Influence of Dehydrated Wheat/Rice Cereal Matrices on Probiotic Activity of Bifidobacterium animalis ssp. lactis BB-12®(§)
por: Leboš-Pavunc, Andreja, et al.
Publicado: (2019)

Review and Perspectives on Bifidobacterium lactis for Infants’ and Children’s Health
por: Tremblay, Annie, et al.
Publicado: (2023)

Transcriptome analysis revealed growth phase-associated changes of a centenarian-originated probiotic Bifidobacterium animalis subsp. lactis A6
por: Wang, Hui, et al.
Publicado: (2022)

Complete genome sequence of the Bifidobacterium animalis subspecies lactis BL3, preventive probiotics for acute colitis and colon cancer
por: Kang, J., et al.
Publicado: (2017)

Protective Effect of Bifidobacterium animalis subs. lactis MG741 as Probiotics against UVB-Exposed Fibroblasts and Hairless Mice
por: Lee, Ji Yeon, et al.
Publicado: (2022)

Immunostimulatory effects of dairy probiotic strains Bifidobacterium animalis ssp. lactis HY8002 and Lactobacillus plantarum HY7717
por: Kim, Ju-Yeon, et al.
Publicado: (2022)

Probiotic treatment with Bifidobacterium animalis subsp. lactis LKM512 + arginine improves cognitive flexibility in middle-aged mice
por: Joho, Daisuke, et al.
Publicado: (2023)

Probiotics attenuate valproate-induced liver steatosis and oxidative stress in mice
por: Song, Wenfang, et al.
Publicado: (2023)

Transcriptional analysis of oligosaccharide utilization by Bifidobacterium lactis Bl-04
por: Andersen, Joakim M, et al.
Publicado: (2013)

Microbiology neutralization of zearalenone using Lactococcus lactis and Bifidobacterium sp.
por: Król, A., et al.
Publicado: (2017)

Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in zebrafish models
por: Chen, Meng, et al.
Publicado: (2022)

Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats
por: Ricoldi, Milla S. T., et al.
Publicado: (2017)

The Probiotic Strain Bifidobacterium animalis ssp. lactis HY8002 Potentially Improves the Mucosal Integrity of an Altered Intestinal Microbial Environment
por: Kim, Joo Yun, et al.
Publicado: (2022)

Glycine max Fermented by a Novel Probiotic, Bifidobacterium animalis subsp. lactis LDTM 8102, Increases Immuno-Modulatory Function
por: Kim, Jae Hwan, et al.
Publicado: (2022)

Potential of Bifidobacterium lactis IDCC 4301 isolated from breast milk‐fed infant feces as a probiotic and functional ingredient
por: Ban, O‐Hyun, et al.
Publicado: (2023)

Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
por: Jiang, Meng, et al.
Publicado: (2019)

Bifidobacterium: a probiotic for the prevention and treatment of depression
por: Li, Jiayu, et al.
Publicado: (2023)

In Vitro Screening for Probiotic Properties of Lactobacillus and Bifidobacterium Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease Prevention
por: Lopez-Escalera, Silvia, et al.
Publicado: (2023)

Locked Nucleic Acid Hydrolysis Probes for the Specific Identification of Probiotic Strains Bifidobacterium animalis subsp. lactis DSM 15954 and Bi-07™
por: Shehata, Hanan R., et al.
Publicado: (2021)

Production and Shelf-Life Study of Probiotic Caja (Spondias mombin L.) Pulp Using Bifidobacterium animalis ssp. Lactis B94
por: Rodrigues, Thais Jaciane Araujo, et al.
Publicado: (2022)

Probiotic Therapy with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis
por: Borshchev, Yury Y., et al.
Publicado: (2022)

Adjuvant Probiotics of Lactobacillus salivarius subsp. salicinius AP-32, L. johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 Attenuate Glycemic Levels and Inflammatory Cytokines in Patients With Type 1 Diabetes Mellitus
por: Wang, Chung-Hsing, et al.
Publicado: (2022)

Transcriptional and Functional Analysis of Bifidobacterium animalis subsp. lactis Exposure to Tetracycline
por: Morovic, Wesley, et al.
Publicado: (2018)

Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research
por: Uusitupa, Henna-Maria, et al.
Publicado: (2020)

Bifidobacterium lactis BB-12 Attenuates Macrophage Aging Induced by D-Galactose and Promotes M2 Macrophage Polarization
por: Zhang, Da-yong, et al.
Publicado: (2019)

Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis
por: Zhao, Yanan, et al.
Publicado: (2022)

Absolute Enumeration of Probiotic Strains Lactobacillus acidophilus NCFM(®) and Bifidobacterium animalis subsp. lactis Bl-04(®) via Chip-Based Digital PCR
por: Hansen, Sarah J. Z., et al.
Publicado: (2018)

Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease
por: Wang, Huan, et al.
Publicado: (2023)

Adhesion mechanisms of Bifidobacterium animalis subsp. lactis JCM 10602 to dietary fiber
por: TANIGUCHI, Maria, et al.
Publicado: (2020)

The Probiotic Combination of Bifidobacterium longum subsp. infantis CECT 7210 and Bifidobacterium animalis subsp. lactis BPL6 Reduces Pathogen Loads and Improves Gut Health of Weaned Piglets Orally Challenged with Salmonella Typhimurium
por: Barba-Vidal, Emili, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lf35t9781gofmdo58ikcjol1g7